Baxter International Inc (BAX) Actualités

Form 8-K/A - Current report: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Baxter Announces CEO Retirement and Appointment of COO

José (Joe) E. Almeida to retire as Chair, President and Chief Executive Officer Lead Independent Director Brent Shafer appointed Chair and...

Form 8-K - Current report

Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on...

Form 8-K - Current report

Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results...

Form 4 - Statement of changes in beneficial ownership of securities

Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday...

Form 4 - Statement of changes in beneficial ownership of securities

Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.

New launches reinforce Baxter’s leadership in bringing high-value, specialty injectable products to market to help address critical patient...

Form 4 - Statement of changes in beneficial ownership of securities